Form D · Biotechnology
Accuitis Inc.
Alpharetta, GA · CIK 0001634848
Offering snapshot reported Aug 31, 2018 · SEC filing
- Reported sold
- $1M Offering amount: $1M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jan 31, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 31, 2018 | Initial | $1,000,000 | No comparison | 22 | SEC filing |
| Sep 5, 2017 | Amendment | $1,750,000 | $750,000vs Jul 1, 2016 | 15 | SEC filing |
| Jul 1, 2016 | Amendment | $1,000,000 | $505,000vs Mar 20, 2015 | 15 | SEC filing |
| Mar 20, 2015 | Initial | $495,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-320471
Source: Form D, filed Aug 31, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Charles Coulon | Director, Executive |
| Stephen Martin | Director |
| Geoff Meacham | Director |
| Michael Shippel | Director, Executive |
| Robert Jason Thomas | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1005 Alderman Drive Suite 104
Alpharetta, GA, 30005
Alpharetta, GA, 30005